ASN 2016

ASN - Amerian Society of Nephrology
November 2016, Chicago, USA

Oral præsentaition
1.Jens Christian Øllgaard
Intensified Multifactorial Intervention in Type 2 Diabetes and Microalbuminuria Reduces End Stage Renal Disease and Mortality: 21 Years Follow-Up of The Steno-2 Study

Poster præsentationer

2. Tine Willum Hansen
Renal sympathetic activity assessed by 123I-MIBG scintigraphy is associated with clinical measures of cardiac autonomic function

3. Emilie Hein Zobel
Pleiotropic Effects of GLP-1 Treatment on Renal Risk Factors in Type 2 Diabetes: Individual Effects of Treatment

4. og 5. Bernt Johan von Scholten
Renal Effects Of Liraglutide In Type 2 Diabetic Patients With Albuminuria: A Randomized Clinical Trial
Effect Of Large Weight Reductions On Measured And Estimated Kidney Function

6. Frederik Persson
NT-proBNP Levels Predict the Individual Drug Response to Aliskiren in Patients with Type 2 Diabetes at High Cardio-Renal Risk